Publications in collaboration with researchers from Johns Hopkins University (3)

2024

  1. Correction to: SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex (Acta Neuropathologica Communications, (2022), 10, 1, (180), 10.1186/s40478-022-01480-y)

    Acta Neuropathologica Communications

2022

  1. SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

2019

  1. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856